Novocure (NVCR) Appoints Allyson J. Ocean to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
Allyson J. Ocean, M.D., Joins Novocure Board of Directors
February 23, 2023 7:00 AM ESTDr. Ocean, a medical oncologist and Associate Professor of Clinical Medicine at Weill Cornell Medicine, brings decades of experience in oncology to Novocure
ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) today announced that Allyson J. Ocean, M.D., has been elected to Novocures Board of Directors.
We are honored to welcome Dr. Ocean to our board of directors, said William Doyle, Novocures Executive Chairman. With her extensive expertise in gastrointestinal oncology and as a practicing clinician, Dr. Ocean will provide important insights and guidance as we strive to... More
